Immunotherapy and gene therapy of cancer.
In the past decade, immunotherapies have been developed that are capable of causing prolonged cancer regressions in selected patients with advanced metastatic disease. In the past year, attempts at the gene therapy of cancer have begun. These experimental cancer treatments deserve vigorous exploration.
Rosenberg
S A
SA
National Cancer Institute, Bethesda, Maryland 20892.
D000818:Animals; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use; D016246:Lymphocytes, Tumor-Infiltrating / Q000502:physiology; D009369:Neoplasms / Q000235:genetics / Q000628:therapy*
D007376:Interleukin-2